(Q52541687)
Statements
Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite. (English)
1 reference
K Randerath
1 reference
B Moorthy
1 reference
N Mabon
1 reference
P Sriram
1 reference
1 October 1994
1 reference
15
1 reference
2087-2094
1 reference
10
1 reference